Mark S. Shearman, EVP, Chief Scientific Officer: Editas Medicine EDIT Sell · Filed 23/02/15

Trade details

Type: Insider sale
Amount: $26,979.3
Shares · price: 2,790 sh · $9.67 a share
Held after: 65,559 sh
Stock: Editas Medicine EDIT
Person: Mark S. ShearmanEVP, Chief Scientific Officer
Trade date: 23/02/13
Filed: 23/02/15
Days to filing: 2 days

Sold 4.1% of holdings

Share of holding sold: 4.1%

Editas Medicine trades, last 26 weeks

What else happened in Editas Medicine around then

Filed or reported within 30 days of the trade day · 23/01/14~23/03/15

Mark S. Shearman's recent trades

No other trades yet.